Ramayana, Toxic and the Rs 15,000-crore question for Indian box office in 2026

The first half of 2026 has just wrapped, and if there is one thing the Indian box office has made clear, it is this: audiences are still willing to show up when a film gives them a reason to.According to India's insights consulting firm Ormax Media, the first six months of 2026 have already delivered Rs 6,398 crore at the Indian box office, the strongest first half since the pandemic (thanks to Dhurandhar: The Revenge and Border 2). More importantly, footfalls have risen 5 per cent year-on-year, suggesting that the growth is not simply the result of higher ticket prices.Now comes the harder half.Ormax Media estimates that, if the historical pattern continues, the Indian box office could cross Rs 15,000 to 16,000 crore in 2026. That would comfortably surpass the current annual record of Rs 13,395 crore, set in 2025. But the road to that number is lined with some of the most expensive and ambitious films Indian cinema has attempted. Ramayana, Toxic, Jailer 2, King, Drishyam 3 and Prabhas' Fauzi are waiting in the wings, each carrying its own promise of spectacle, superstardom or franchise familiarity.And then there is Hollywood, with Avengers: Doomsday and Dune: Part Three entering the same race for the audience's time and money, following its predecessors The Odyssey and Spider-Man: Brand New Day.The films carrying the weight of the year At the heart of that conversation is Nitesh Tiwari's Ramayana: Part 1.Few Indian films have arrived with this kind of expectation. Ranbir Kapoor plays Lord Ram, Sai Pallavi is Sita, Yash is Ravana and Sunny Deol is Lord Hanuman. Mounted as a two-part epic by Namit Malhotra, the film is being built on a scale rarely seen in Indian cinema. DNEG is handling the visual effects, while Hans Zimmer and AR Rahman are working on the music.The often-repeated Rs 4,000-crore figure refers to the two-part project, rather than the first film alone. Even so, the number tells us something about the ambition behind it. Ramayana is not being made merely to become another Indian blockbuster. It is being designed as a global theatrical spectacle.That changes the meaning of success.A film carrying an investment of this magnitude needs more than a huge opening weekend. It needs sustained theatrical momentum, strong overseas business and enough audience interest to create a bridge to Part 2. It needs to become an event that extends beyond the fan base of its stars. For Indian cinema, Ramayana is almost a test case: can a story deeply rooted in Indian mythology be packaged at an international scale and find an audience far beyond India?If it succeeds, the ceiling moves. If it doesn't, the industry will have an uncomfortable conversation about how much money can realistically be put behind a single theatrical bet.Yash's next gambleIf Ramayana represents mythological grandeur, Yash's Kannada release Toxic: A Fairy Tale for Grown-Ups is betting on something darker.Directed by Geetu Mohandas, the gangster drama is set in post-Independence Goa and features Kiara Advani, Nayanthara, Huma Qureshi, Tara Sutaria and Rukmini Vasanth alongside Yash. The film has been through delays and changes, but its scale has remained one of its biggest talking points.As per reports, budget estimates have varied dramatically, from around Rs 500 crore to close to Rs 1,000 crore. That is an enormous number for a film that has to work across languages and territories.Yash, of course, is not entering this race without ammunition. KGF turned him into one of Indian cinema's most recognisable pan-India stars. But that success is also the problem: Toxic will inevitably be judged against the phenomenon that came before it.The audience may give a superstar a big opening. It cannot guarantee him a long run. For Toxic to become the kind of blockbuster its scale demands, the film will need both: the initial Yash-driven rush and the word of mouth that keeps the screens occupied after it. Stars, franchises and familiar worldsShah Rukh Khan's King comes with a different kind of advantage: the enduring pull of a superstar who has already demonstrated his ability to turn theatrical releases into national events.Directed by Siddharth Anand, King pairs Shah Rukh with Suhana Khan in her theatrical debut and features Deepika Padukone, Rani Mukerji and a large supporting cast. Budget estimates have hovered around Rs 350–450 crore, although the filmmakers have pushed back against some of the larger claims surrounding its cost.Although its 2026 release is dicey, and if it does, the film's Christmas release gives it another advantage. Holiday periods remain among the safest spaces for big-ticket cinema, when families, young audiences and occasional moviegoers are all more willing to head to theatres. SRK's King title reveal poster. (Credit: Instagram/Shah Rukh Khan) But King also arrives at an interesting moment. The post-pandemic audience has become less willing to turn up simply because a familiar star is on a poster. The film has to offer something worth leaving home for. That is the larger test for star-driven cinema in 2026: can the star still be the event, or does the film have to become the event?Drishyam 3 has a slightly safer path.Ajay Devgn returns as Vijay Salgaonkar, with Tabu and the familiar ensemble coming back for the third chapter. Unlike an original big-budget spectacle, Drishyam already has something invaluable: an audience that knows the world and cares about its characters.The Malayalam franchise has further strengthened the brand, with Mohanlal's Drishyam 3 performing strongly. According to industry tracking site Sacnilk, the film crossed Rs 100 crore in the first 58 hours. It went on to earn around Rs 240 crore gross globally. For the Hindi version, the commercial equation is therefore less about breaking every possible record and more about delivering a profitable continuation of a proven franchise.And that distinction matters. Not every successful film needs to cost Rs 500 crore.The surprise hits could matter moreFor all the attention on the giants, the most revealing stories of 2026 may come from films that do not arrive with giant price tags.Awarapan 2 offered a reminder of how quickly audience priorities can shift. Released alongside Sunny Deol's Batwara 1947, the Emraan Hashmi-led sequel found stronger audience traction despite carrying considerably less pre-release noise and star power. While the gangster drama minted around Rs 20 crore net in its opening, the latter opened at just Rs 5.75 crore, as per Sacnilk.That is not an argument against stars. It is an argument for curiosity.Theatrical audiences are increasingly making films compete on the basis of what they offer, not simply who is in them. A good thriller can beat a star vehicle. A rooted regional drama can travel. A comedy can become a sleeper hit. A sequel nobody expected to dominate can suddenly become the film everyone is discussing.This is where the regional industries become crucial.Tamil, Telugu, Kannada and Malayalam cinema have repeatedly demonstrated that scale does not always have to mean enormous budgets. A sharply written story, a strong genre hook and genuine word of mouth can turn a relatively modest investment into a substantial theatrical return.Having a relatively flimsy box office run over the past few releases, Prabhas' December release, Fauzi, is one such name. It is another film carrying the weight of a major theatrical bet. With a reported budget of around Rs 600-700 crore, the period action-drama is being mounted as a large-scale Telugu production with pan-India ambitions. Prabhas' Fauzi releases on December 3, 2026. (Credit: Instagram/Prabhas) Its biggest asset, however, is not simply the money on screen but Prabhas himself, whose post-Baahubali and Salaar appeal gives the film a ready-made national audience. Yet Fauzi will need more than a big opening to justify its scale.And that is precisely what the Rs 15,000-crore target needs.The box office cannot live on five or six tentpoles alone. There need to be films filling the gaps between them – movies that keep audiences coming back when there is no Ramayana or King to pull them in.Then come the global blockbustersIndian cinema will not have the second half of 2026 to itself.Hollywood has already shown what a strong second half can look like. According to Box Office Mojo, Spider-Man: Brand New Day swung into theatres with a spectacular $927 million worldwide opening weekend and has since crossed $1.7 billion globally. Christopher Nolan's The Odyssey has been just as striking, surpassing $1.1 billion to become the filmmaker's highest-grossing film. Together, they have underlined the appetite for big-screen spectacle – and set an even higher bar for the Indian blockbusters still to come.Dune: Part Three brings Denis Villeneuve's acclaimed science-fiction franchise back to cinemas, with a reported production budget in the region of $200-220 million. Then comes Avengers: Doomsday, perhaps the biggest Hollywood competitor in the calendar. Its reported production budget is around $400 million, with marketing potentially taking the total investment towards $700 million. For Indian exhibitors, these films represent competition for premium screens and urban audiences. But they also contribute to the same phenomenon that Indian cinema is chasing: making a trip to the cinema feel like an occasion.The real battle, therefore, is not necessarily India versus Hollywood. It is event cinema versus everything else.The Rs 15,000-crore questionBefore we jump into further explanation, Rs 15,000 crore is not the target. It is the staggering amount of money riding on the films that will define Indian cinema's second half of 2026.Ramayana has to justify an unprecedented scale. Toxic has to prove that pan-India stardom can translate into sustained theatrical business. King has to show that superstar power still carries commercial weight, while Drishyam 3 will test whether a familiar franchise can remain profitable without needing an astronomical budget. Prabhas' Fauzi, and Mirzapur: The Movie, add yet more major bets to an already crowded field.But the real story may not belong to the films carrying the biggest price tags.There will be smaller films, across Hindi, Tamil, Telugu, Kannada and Malayalam cinema such as Vazha 2, DC or Mollywood Times, etc, arriving with less noise, fewer expectations and considerably less money behind them. Some of them could quietly become the year's most efficient performers.That is what makes the second half so intriguing. The health of the theatrical business will not be measured by how many thousands of crores a handful of tentpoles collect, but by how widely that money is distributed across the industry. If the big spectacles deliver and the smaller films continue to surprise, 2026 could become more than a record year. It could signal a healthier, broader theatrical recovery.After all, the most important number is not how much Indian cinema spends on a film. It is how many people still feel that film is worth leaving home for.- EndsPublished On: Aug 17, 2026 07:31 IST